Manufactures and sells agrochemical products, including technicals (active ingredients) and formulations, through three revenue streams. Domestic B2B contributes 40% of revenue (sells technicals to other formulators), domestic B2C contributes 40% (sells formulations through 5,000 distributors and 24 C&F locations to farmers), and exports contribute 20% across 37 countries. The business runs an integrated model with two technical manufacturing plants and one intermediate plant, with a current product mix of about 75% formulations and 25% technicals. Technical plants are presently operating at 70-75% utilisation, with management indicating peak technicals revenue potential of INR1,900-2,000 crores at around 90% utilisation. R&D is patent-led, with 102 patents received, 108 in the pipeline and 12 commercialised so far; a 10-15% price hike was implemented from 1 April 2026 to pass on raw material cost inflation. Raw materials are the largest cost at 61.5% of revenue, followed by other operating expenses at 17.5%. The firm listed on NSE and BSE in March 2026 through an IPO of 75 lakh fresh shares at Rs 320 each. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Domestic B2B (40%), Domestic B2C (40%), Exports (20%). Integrated, patent-led agrochemical manufacturer with formulation and technicals capabilities
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 1,517 |
| EBITDA (ex other income) | 181 |
| margin % | 11.9 |
| Owners' profit | (3) |
| EPS, as reported (₹) | 24.93 |
| ROE % · ROCE % | 12.3 · 20.2 |
| Debt / equity (x) | 0.34 |
| Cash from operations | 59 |
| Capex | (77) |
| ₹ crore | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|
| Revenue | 270 | 402 | 386 |
| Profit before tax | (8) | 27 | 35 |
| Net profit | (6) | 20 | 26 |
| EPS (₹) | (1.38) | 5.09 | 5.67 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 48,414 | 23.7 | 1.17 | 6.5 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 34,337 | 29.4 | 3.06 | 16.2 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 23,762 | 41.0 | 7.00 | 29.6 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 17,895 | 26.0 | 6.03 | — | 23.2 | 27.3 | — | 22.7 |
| SHARDA CROPCHEM LTD. | 6,910 | 11.0 | 2.20 | 5.7 | 21.7 | 25.2 | 17.1 | 20.5 |
| DHANUKA AGRITECH LTD | 4,359 | 14.9 | 3.11 | 9.7 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD | 3,833 | 23.9 | 2.26 | 12.9 | 9.7 | 12.5 | — | 0.9 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · GSP Crop Science responds to NSE query on sharp rise in trading volume | regulatory legal | medium | — | — |
| 8 Sept 2026 · NSE flags unusual trading volume; seeks clarification from company | compliance | low | — | — |
| 25 Aug 2026 · GSP Crop Science publishes 41st AGM notice in newspapers | compliance | minimal | — | — |
| 24 Aug 2026 · Letter to shareholders with FY25-26 Annual Report web link, 41st AGM on September 18, 2026 | compliance | minimal | — | — |
| 24 Aug 2026 · GSP Crop Science files FY26 Annual Report, AGM on Sept 18 | board shareholder meetings | medium | — | — |
| 24 Aug 2026 · GSP Crop Science 41st AGM on September 18, 2026 with final dividend | board shareholder meetings | medium | — | — |
| 21 Aug 2026 · GSP Crop Science announces AGM and dividend record date via newspaper ads | compliance | minimal | — | — |
| 20 Aug 2026 · GSP Crop Science fixes Sept 11, 2026 as record date for FY26 dividend | corporate actions | high | — | — |
| 17 Aug 2026 · GSP Crop Science Q1 FY27 earnings call transcript filed | investor communications | medium | — | — |
| 13 Aug 2026 · Q1 FY27 earnings call audio recording uploaded | investor communications | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| NACL INDUSTRIES LIMITED | 3,709 | 310.4 | 5.43 | 45.4 | 0.7 | 1.4 | 5.9 | 11.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 50.3 | 20.1 | 24 of 27 | 12% |
| P/B | 2.9 | 2.4 | 18 of 28 | 37% |
| ROCE | 15.6 | 12.5 | 8 of 29 | 75% |
| ROE | 12.3 | 9.2 | 7 of 28 | 78% |
| Debt / Equity | 0.3 | 0.3 | 16 of 29 | 46% |
| EBITDA margin | 13.2 | 14.8 | 16 of 28 | 44% |
| Market cap | 2193 | 1540 | 10 of 29 | 68% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
